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Invasive infections caused by Streptococcus suis serotype 2 (SS2) has emerged as a
clinical problem in recent years. Neutrophil extracellular traps (NETs) are an important
mechanism for the trapping and killing of pathogens that are resistant to phagocytosis.
Biofilm formation can protect bacteria from being killed by phagocytes. Until now,
there have only been a few studies that focused on the interactions between bacterial
biofilms and NETs. SS2 in both a biofilm state and a planktonic cell state were
incubated with phagocytes and NETs, and bacterial survival was assessed. DNase
I and cytochalasin B were used to degrade NET DNA or suppress phagocytosis,
respectively. Extracellular DNA was stained with impermeable fluorescent dye to quantify
NET formation. Biofilm formation increased up to 6-fold in the presence of neutrophils,
and biofilms were identified in murine tissue. Both planktonic and biofilm cells induced
neutrophils chemotaxis to the infection site, with neutrophils increasing by 85.1 and
73.8%, respectively. The bacteria in biofilms were not phagocytized. The bactericidal
efficacy of NETs on the biofilms and planktonic cells were equal; however, the biofilm
extracellular matrix can inhibit NET release. Although biofilms inhibit NETs release,
NETs appear to be an important mechanism to eliminate SS2 biofilms. This knowledge
advances the understanding of biofilms and may aid in the development of treatments
for persistent infections with a biofilm component.
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INTRODUCTION
Streptococcus suis (SS) is a major swine pathogen that causes a variety of diseases such as septicemia,
meningitis, and endocarditis, which lead to economic losses. S. suis serotype 2 (SS2) is considered
the most pathogenic and prevalent capsular type (Wertheim et al., 2009; Kerdsin et al., 2016).
People working with pigs or people who consume pork-derived products from infected animals
are at risk. During the last decade, several human epidemic outbreaks were reported in Asia
and all over the world (Gottschalk et al., 2010a,b; Goyette-Desjardins et al., 2014). In addition,
streptococcus toxic shock-like syndrome (STSLS), a peracute infection characterized by shock and
a high mortality rate, is reported to be caused by SS2, resulting in increased public health concerns
worldwide (Tang et al., 2006; Gomez et al., 2014).
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Bacterial biofilms are bacterial communities and are an
important mechanism for bacterial resistance to immune system
pressures and antimicrobials (Bojarska et al., 2016). Most of
SS2 clinical isolates can form biofilms, which contribute to
persistent infection, transmission and difficulties to eradicate
infection (Bojarska et al., 2016). However, little information is
available on the interaction between the host immune system
and SS2 biofilms (Thurlow et al., 2011; Yang et al., 2016).
Neutrophil extracellular traps (NETs), which are composed
of granule and nuclear constituents, are made by activated
neutrophils (Brinkmann et al., 2004; Uhlmann et al., 2016).
The nuclear constituents are DNA and histones; DNA is the
backbone of NETs and traps the pathogens by charge interactions
(Wartha et al., 2007). In the recent years, NETs have been
identified as a significant antibacterial mechanism employed
by neutrophils (Csomos et al., 2016). Neutrophils are observed
to generate NETs upon activation with interleukin-8 (IL-8),
phorbol myristate acetate (PMA), lipopolysaccharide (LPS), and
various microbes (Leshner et al., 2012). NETs can disarm and
kill a variety of pathogens, including GAS, S. aureus, Shigella
flexneri, and fungi, by capturing the microbes and providing a
high local concentration of antimicrobial granules (Brinkmann
et al., 2004; Buchanan et al., 2006; May et al., 2015). NETs
have been found to be abundant at in vivo sites of infection
and inflammation, including in cases of the autoimmune
disease systemic lupus erythematosus and a murine model of
pneumococcal pneumonia (Beiter et al., 2006; Hakkim et al.,
2010).
In previous studies examining the immune system response
to various microorganisms, certain microbes have been shown to
evade phagocytosis but become entrapped by NETs (Branzk et al.,
2014). Candida albicans biofilms evade phagocytosis and impair
NET formation (Johnson et al., 2016). However, the nature of
bacteria and fungi is dramatically different, particularly in size
and biofilm structure. Therefore, whether bacterial biofilms can
stimulate NET formation is unknown and the influence of SS2
biofilms on bacterial survival in NETs is unclear and requires
exploration.
Bacterial biofilm formation allows bacteria to persist in
the host, making the treatment of streptococcosis challenging
(Walker et al., 2005). Cases of human infections worldwide stress
the lack of knowledge on the virulence and interactions with
host immune cells. Our study provides further knowledge on
SS2 biofilm and immune response interactions, which can lead
to novel approaches to streptococcosis clinical therapy. Further
understanding of host-SS2 interactions may help to explain the
complex evolution of the emerging human threat.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in an accordance to animal welfare
standards and were approved by the Ethical Committee for
Animal Experiments of Nanjing Agricultural University, China.
All animal experiments accorded with the guidelines of the
Animal Welfare Council of China.
Bacterial Strains and Cells
The wild-type SS2 strain ZY05719 is an isolate from Jiangsu
Province and was grown in Todd-Hewitt broth (THB) medium
(Difco, BD, Franklin, NJ, USA) at 37◦C on a gently rocking
shaker. The bacteria were cultured to the mid-exponential
phase and were collected in media for the experiment using
planktonic cells. SS2 biofilms were identified with Congo Red
Agar composed of 3% THB, 0.08% Congo Red (Sigma Aldrich,
St. Louis, Mo, USA), 0.5% glucose (Biosharp, Anhui, China)
and 1.5% agar powder. Neutrophils from the bones of mice
were cultured in RPMI 1640 (Gibco-BRL, Thermo Fisher
Scientific, Waltham, MA, USA) supplemented with 2% heat-
inactivated fetal bovine serum (FBS) at 37◦C in 5% CO2.
RAW264.7 cells (ATCC R© TIB-71TM) were purchased from the
American Type Culture Collection (ATCC) and were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Wisent, Canada)
supplemented with 10% FBS at 37◦C in 5% CO2.
Isolation of Neutrophils from Mouse Bone
Marrow
Neutrophils were isolated from 4-week-old ICR mice as
previously described with modifications (Zhao et al., 2015).
Briefly, the mice were euthanized and sprayed with 70% ethanol.
The bone marrow from the tibias and femurs was flushed with
sterile PBS with a 20-gauge needle into a 15 ml Falcon tube (BD
Falcon), and the cells were washed by centrifugation at 400 × g
for 10 min. The cell pellet was resuspended in 3 ml of PBS. A
Percoll (Sigma Aldrich) density gradient was prepared in a 15
ml Falcon tube by the careful addition of 3 ml of 80% Percoll
followed by 3 ml of 65% Percoll and 3 ml of 55% Percoll. The
cell suspension was overlaid carefully and centrifuged for 30
min at 1000 × g at room temperature. The top layer and the
55% Percoll layer were carefully aspirated and discarded. The
cells at the 80/65% gradient interface were collected and then
washed and suspended in RPMI1640 medium. A greater than
90% neutrophil purity was confirmed by Trypan blue staining
and flow cytometry.
Neutrophil Detection by Flow Cytometry
Flow cytometry was performed as previously described with
modification (Barletta et al., 2012). The neutrophils were stained
with 0.1µg of FITC-mouse Ly6G antibody (eBioscience, San
Diego, CA, USA) and 0.1µg of PE-mouse CD11b antibody
(eBioscience). All of the experiments were recorded using Accuri
Cflow software (BD Bioscience, CA, USA) and were analyzed
using FlowJo software (Three Star, Ashland, OR, USA).
Biofilm Formation In vitro
SS2 biofilm formation required the presence of fibrinogen in the
culture medium (Freeman et al., 1989; Bojarska et al., 2016). For
SS2 biofilm formation in vitro, 100µl of THB with 2.5 mg/ml
of human plasma fibrinogen (Sigma Aldrich) and 100µl of the
bacterial suspension at a concentration of 106 colony forming
units (CFU)/ml were incubated in a 96-well plate at 37◦C for 24 h.
Each well was washed carefully with PBS to remove planktonic
bacteria. For biofilm experiments, the biofilms were resuspended
in PBS by repeated pipetting, through which the biofilms were
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physically dispersed (Johnson et al., 2016). To detect the effect of
neutrophils on SS2 biofilm formation, 100µl of a 104 CFU/ml
bacteria suspension in RPMI was mixed with 100µl of purified
neutrophils at 106/ml with or without DNase I or cytochalasin B
in a 96-well plate and incubated for 24 h at 37◦C in 5% CO2. The
purified neutrophils without bacteria were included as a negative
control. DNase I and cytochalasin B were added to bacterial
suspension only in the presence of fibrinogen to evaluate the
influence of these two inhibitors on biofilm formation.
Biofilm formation in the above assay was detected in a 96-
well plate using a 0.1% crystal violet stain (Kosikowska et al.,
2016). After incubation for 24 h, the plates were washed three
times with PBS to remove nonadherent cells. To each well, 200µl
of methyl alcohol was added to fix the cells, and then the plates
were placed in a 37◦C dryer oven to remove the methyl alcohol.
After the plates were washed with PBS three times, the biofilm
in each well was stained with 200µl of 0.1% crystal violet for
20 min. Following staining, the plates were washed three times,
and the crystal violet staining the cells was dissolved with 95%
ethyl alcohol. The biofilm was detected with a multifunctional
microplate reader (Tecan Infinite Pro, Austria) at an optical
density (OD) of 595 nm.
Biofilm Detection In vivo
To determine whether SS2 forms biofilms in vivo, the bacteria
were grown to an OD600 of 0.8 and were then washed three times
with PBS. Four-week-old ICR mice were challenged with SS2
ZY05719 at 108 CFU/ml by intraperitoneal injection. Three days
post-injection, the mice were challenged again. At 12 h after the
injection, the mice were euthanized, and the heart, liver, spleen,
lungs, and kidneys were collected and homogenized. SS2 biofilm
formation was determined using plate streaking in modified
Congo Red THB plate agar. In order to exclude the color change
of Congo Red THB plate is caused by planktonic bacteria or
tissue homogenate, planktonic ZY05719 was added into organs
homogenate of non-injected mice and the mixture was streaked
on Congo Red THB plate directly. The bacteria isolated in
vivo were detected with polymerase chain reaction (PCR) using
the primer combinations GAPDHF/GAPDGR to detect SS2
GAPDH: forward, 5′-CATGGACAGATAAAGATGG-3′; reverse,
5′-GCAGCGTATTCTGTCAAACG-3′ and CPSF/CPSR to detect
the SS2 serotype: forward, 5′-GACGGCAACATTGTTGAGTC-
3′; reverse, 5′-CTCCTAACCACTGTTCAGTG-3′.
Phagocytosis Assay
The phagocytosis assay was performed with RAW264.7 cells
as previously described with some modifications (Mitterstiller
et al., 2016). Briefly, RAW264.7 cells were incubated in 24-
well plates, and then the cell monolayers were washed three
times with PBS. An aliquot (100µl) of suspension containing
106 CFU/ml planktonic cells or biofilm cells were added to the
cells. The 24-well plate was centrifuged at 800 × g for 10 min
and was incubated for 2 h at 37◦C in 5% CO2. Next, the cells
were washed with DMEM and were treated with 200µg/ml of
penicillin-streptomycin for 1 h to kill extracellular bacteria. The
cells were washed with DMEM, and then 100µl of trypsin and
900µl of sterile deionized water were added per well to release the
bacteria. The viable bacteria number was determined by plating
serial dilutions. Bacteria incubated in DMEM for 2 h without
RAW264.7 cells were served as control group to quantify the
initial inoculum. The level of phagocytosis was calculated as
(CFUs of viable bacteria in experimental group)/(CFUs of viable
bacteria in the control group).
Neutrophil and NET Bactericidal Assays
The neutrophils bactericidal assay was performed according to
a previous method with slight modifications (Uchiyama et al.,
2015). The neutrophils were divided into 3 groups: an untreated
group containing only purified neutrophils, and two groups of
neutrophils were treated with either DNase I (Sigma Aldrich) to
inhibit NET formation or with cytochalasin B (Sigma Aldrich) to
suppress neutrophil phagocytosis. Bacteria at 3 × 107 CFU were
added to the neutrophils at a multiplicity of infection (MOI) of
10. After incubation with planktonic SS2 or biofilm cells for 90
min, the neutrophils were permeabilized with 0.2% Triton X-100
(Sigma Aldrich) on ice to release the intracellular bacteria. The
surviving bacteria were diluted and plated on THB agar, and the
CFUs were counted. Bacteria without incubation were serially
diluted and plated to quantify the initial inoculum.
The neutrophils were stimulated by PMA (200 nM, Sigma
Aldrich) for 4 h to form NETs as previously described (Ma et al.,
2017). Thereafter, the mixtures were centrifuged at 800 × g for
10 min to remove the cells. Planktonic SS2 and biofilm cells at
2 × 107 CFU were added to the NET supernatant and were
incubated for 1 h at 37◦C in 5% CO2. The bacteria without
incubation in NETs supernatant were diluted and plated on THB
agar as a control.
Bacterial Survival in Mouse Blood In vivo
Bacterial survival in the blood was determined as previously
described (Derkaoui et al., 2016). An aliquot (200µl) of
planktonic or biofilm SS2 at an OD600 of 0.5 was injected into
mice via the tail vein route. To further evaluate the function of
NETs, the bacteria were injected into the tail vein with DNase
I (10 mg/kg of body weight), and at 12 h post-infection, DNase
I was injected again. Planktonic and biofilm SS2 cells without
incubation were plated on THB agar as a control. At 2, 4, 8, and
24 h post-infection, blood was collected via heart puncture, and
the blood was serially diluted and plated on THB agar plates.
Visualization and Quantification of NETs
In vitro
NETs were observed in vitro as previously described (Yost et al.,
2016). Briefly, neutrophils were pretreated with cytochalasin
B for 15 min before incubation with PMA and bacteria.
Planktonic ZY05719 at an OD600 of 0.6–0.8 were washed
twice with PBS, added to the neutrophils at an MOI of
10 on poly-L-lysine-coated cover slides, and then centrifuged
at 800 × g for 10 min. After incubation at 37◦C for 3
h, the cover slides were fixed with 4% paraformaldehyde
for 10min, permeabilized with 0.1% Triton X-100 and were
then blocked with donkey serum at 4◦C overnight. The
samples were stained with the primary rabbit anti-neutrophil
histone H4 antibody (citrulline 3, 1:1000 diluted, Merck
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Millipore, Billerica, MA, USA) for 1 h at RT, followed by
incubation with goat anti-rabbit Alexa 568 antibody (1:100
dilution, Jackson ImmunoResearch, West Grove, PA, USA).
The DNA was visualized by staining with 4’,6-diamidino-2-
phenylindole (DAPI, Thermo Fisher). The images were recorded
using a fluorescence microscope (Zeiss, Germany). Bacteria
entrapped by NETs were stained with SYTO 9 green fluorescent
nucleic stain (Thermo Fisher) and observed using 100 × oil
objective.
The NET quantification assay was performed as previously
described (Riyapa et al., 2012). For determining the capacity of
neutrophils to form NETs in the presence of planktonic and
biofilm SS2, 200µl of neutrophils were incubated with 20µl
of planktonic SS2 cells, biofilm cells or bacteria separated from
biofilm matrix with or without PMA for 3 h. The biofilms were
disrupted and themixture was centrifuged at 3,000× g for 10min
to separate the bacteria from biofilmmatrix. The supernatant was
biofilm extracellular matrix and was collected. The precipitate
was bacteria that were separated from matrix and the bacteria
were washed 3 times with PBS. As a positive control, neutrophils
were stimulated with 200 nM PMA. The corresponding bacteria
or biofilmmatrix were incubated inmedia without neutrophils to
eliminate the background fluorescence. The negative control was
the purified neutrophils incubated in media. Extracellular DNA
was used to evaluate the quantity of NETs, which was quantified
using a Quant-iT Picogreen dsDNA assay kit (Invitrogen).
Briefly, after incubation, the reaction mixture were centrifuged
at 800 × g for 5 min to discard the cells. Subsequently, 100µl
of supernatant was added to 100µl of a working solution,
which was then mixed thoroughly. After incubation for 5 min,
the fluorescence was read with a multifunctional microplate
reader (Tecan Infinite Pro) at 480 nm (excitation)/520 nm
(emission).
Statistical Analysis
All experiments were repeated at least 3 times. Student’s t-test and
the GraphPad Prism 5 Software package (GraphPad Software, La
Jolla, CA, USA) were used to perform statistical analyses. Values
of p < 0.05 were considered statistically significant.
RESULTS
SS2 Biofilm Formation Improved in the
Presence of Neutrophils
Wild-type SS2 can form biofilms only in the presence of
fibrinogen in vitro; however, we found that wild-type SS2 can
form biofilms without fibrinogen in the presence of neutrophils.
Either phagocytosis or NETs of neutrophil is inhibited, the
formation of SS2 biofilm decreased (Figures 1A,B). DNase I and
cytochalasin B were used to degrade NET DNA and inhibit
phagocytosis and these two inhibitors had no influence on SS2
biofilm formation in the presence of fibrinogen (Figure 1C). This
results suggest that in the presence of neutrophil infiltration, SS2
is more liable to form biofilms, which may enhance bacterial
survival.
Identification of SS2 Biofilms in Mouse
Organs
Considering that SS2 biofilm formation in THB requires
fibrinogen, it is necessary to determine whether SS2 forms
biofilms in vivo. Biofilm formation can cause a color change of
the Congo Red Agar from red to black. Importantly, biofilm SS2
was isolated from the liver, spleen, and kidney of healthy mice
challenged with planktonic SS2 (Figure 2A). Control groups are
designed to evaluate the influence of planktonic bacteria and
tissue homogenate on Congo Red Agar, and the results showed
that normal tissue homogenate, planktonic SS2 and even their
simple mixtures cannot cause a color change of the Congo Red
Agar (Figure 2B). The isolated biofilm cells were confirmed by
PCR (Figure 2C).These results indicated that SS2 could form
bacterial biofilms during the process of infection.
Chemotaxis of Neutrophils to the Site of
Infection Site with Planktonic and Biofilm
Cells
The mice were infected with biofilms and planktonic SS2 at
the same OD600 using the murine peritoneal infection model;
then, mouse immune cells were collected from peritoneal lavage
fluids. Cells collected from mice without infection were served
as blank control (Figure 3A). The results indicated that both
planktonic and biofilm cells caused a significant increase in
neutrophils in the peritoneal cavity, from 2.4 to 87.5% and 76.2%,
respectively (Figures 3B,C). The neutrophil infiltration provides
an environment for the interaction between neutrophils and
pathogens.
Phagocytosis Efficiency of Biofilm Cells
and Planktonic Cells
The results of the phagocytosis assay indicated that
approximately 40% of planktonic SS2 can be engulfed by
RAW246.7 cells, a type of professional phagocyte. However, only
a few biofilm cells could be plated on THB agar, which indicated
that it was more difficult to engulf biofilm SS2 (Figure 4A).
Purified neutrophils had a significant bactericidal effect, and
the survival capability of biofilm SS2 was nearly twice that of
planktonic SS2. When DNase I was added with neutrophil, the
survival rate of planktonic bacteria were nearly 2 times greater
than that of the corresponding untreated group. The bacterial
survival rate in the biofilm group with DNase I treatment was
nearly 30% higher than that of the corresponding untreated
control group. For planktonic SS2, when neutrophil phagocytosis
was suppressed, the survival rate of planktonic SS2 was increased
significantly. However, regardless of phagocytosis inhibition,
there was little influence on the survival capability of the biofilm
cells (Figure 4B). Importantly, the results showed that the
inhibition of phagocytosis was more beneficial for the survival of
planktonic SS2 than the degradation of NETs, while NETs appear
to play an important role in biofilm SS2 elimination.
NETs Bactericidal Activity
To evaluate the bactericidal capacity of NETs, the NETs
bactericidal assay was performed. In the presence of NETs,
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FIGURE 1 | Neutrophil impact on SS2 biofilm formation in vitro. SS2 ZY05719 (referred as ZY in figures) biofilm quantification using crystal violet staining.
(A) The biofilms were quantified using a multifunctional microplate reader at OD 595. When DNase I and cytochalasin B (referred as cytB in figures) were added, the
biofilm formation capability decreased up to five-fold. The results are depicted as the mean ± SD (n = 5). ***p < 0.001. (B) The corresponding photos of biofilms
stained with crystal violet are shown. (C) The influence of DNase I and cytochalasin B on SS2 biofilm formation in the presence of fibrinogen. These two inhibitors have
no effect on SS2 biofilm formation.
FIGURE 2 | Biofilm formation in SS2 infected mice. (A) At 12 h after the second injection with SS2 ZY05719, the mouse organs were homogenized, and the
bacterial colonies were examined on modified Congo Red THB agar. Biofilm cells isolated from the liver, kidney and spleen can cause a red to black color change.
(B) Organs collected from healthy mice were homogenized and mixed with planktonic SS2 ZY05719. The mixtures were streaked on Congo Red THB agar.
Planktonic bacteria, tissue homogenate and their simple mixtures cannot cause a color change. (C) Isolated bacteria were confirmed as SS2 by PCR. A PCR product
of 688-bp indicated the presence of SS2 GAPDH, and the 270-bp product indicated the presence of the SS2 capsule.
nearly 25% of planktonic and 20% of biofilm SS2 cells
were killed according to viable bacteria quantification on
THB agar (Figure 5). The result indicated that NETs could
kill both planktonic and biofilm SS2 and the bactericidal
efficiency of NETs on planktonic SS2 and biofilm cells was
comparable.
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FIGURE 3 | Proportion of neutrophils in peritoneal washes induced by planktonic and biofilm SS2. Neutrophils were marked with PE-conjugated anti-CD11b
antibody and FITC-conjugated anti-Ly6G antibody. (A) Neutrophils comprised 2.4% of the cells collected from mice injected with the PBS control. (B,C) Neutrophils
comprised 87.5 and 76.2% of cells collected from mice infected with planktonic and biofilm SS2, respectively.
FIGURE 4 | Phagocytosis by RAW264.7 cells and bactericidal activity of neutrophils. (A) Planktonic and biofilm SS2 cells were phagocytized by RAW264.7,
and 40% of planktonic SS2 cells were phagocytized; however, few biofilm SS2 cells were phagocytized. (B) Planktonic and biofilm SS2 cells were killed by
neutrophils, and the survival rate of biofilm cell was almost twice that of planktonic cells. When neutrophils were treated with DNase I and cytochalasin B, the survival
rate of planktonic cells were increased by 2-fold and 3-fold, respectively. When neutrophils were treated with DNase I, the viable biofilm cells increased significantly;
however, when neutrophils were pretreated with cytochalasin B, there was no significant difference between the untreated control and pretreatment groups. The
results are depicted as the mean ± SD (n = 5). ***p < 0.001; ns, no difference between the groups.
Inhibition of NET Formation by SS2 Biofilm
Because NET formation is an important mechanism to kill
SS2 biofilm, we next examined whether SS2 biofilms induced
NET formation by neutrophils. SS2 ZY05719 could induce NETs
release and could be captured by the NETs (Figures 6A,B).
To further study the influence of biofilms on NET formation,
the NETs quantification assay was developed. Only planktonic
SS2 and bacteria separated from biofilm extracellular matrix
could stimulate NETs release compared to biofilm cells.
Importantly, the supernatant of the dispersed biofilm mixture,
which is mainly composed of biofilm extracellular matrix,
could not stimulate NET formation. In this case, bacteria
were incubated with PMA stimulated neutrophils to determine
whether biofilms failed to activate neutrophils or inhibit
NET formation. The extracellular DNA of NETs induced by
planktonic SS2 and bacteria separated from biofilm matrix was
enhanced by PMA; however the biofilms and biofilm extracellular
matrix inhibited PMA-induced NETs as well (Figure 6C).
These results indicated that bacteria both from the planktonic
state and the dispersed biofilm state can stimulate NETs
release; however, the extracellular biofilm matrix inhibited NET
formation.
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FIGURE 5 | Bactericidal capability of NETs. The bactericidal rate was
calculated by viable bacteria quantification on THB agar. The results are
depicted as the mean ± SD (n = 5). ns, no difference between groups.
Survival of Planktonic and Biofilm SS2
In vivo
Following the observation that NETs kill both planktonic SS2
and biofilm SS2 in vitro, we aimed to identify the function of
NETs in blood in vivo. In the first 8 h post-infection, both viable
planktonic SS2 and viable biofilm SS2 cells decreased. This result
may be ascribe to the host immune response. However, biofilm
SS2 survived better than the planktonic cells in the blood stream.
Notably, the survival of planktonic and biofilm SS2 was enhanced
when NETs were degraded by DNase I. When NETs were
destroyed with DNaseI, The viable bacteria in biofilm was much
more than planktonic bacteria after 2 h post-infection (Figure 7).
These results confirmed that biofilm SS2 demonstrated enhanced
survival in the host, particularly when NET DNA was
degraded.
DISCUSSION
SS2 is an important emerging zoonotic pathogen in humans
(Smith et al., 2001; Goyette-Desjardins et al., 2014). Most
of SS2 human invasive isolates formed biofilm according
to previous studies (Bojarska et al., 2016). Bacterial biofilm
formed on host surfaces, which is critical to the virulence
of these organisms. Neutrophils initiate potent response to
evasive pathogens and surveille the tissue in the circulation,
which plays an essential role in innate immunity (Nicolas-
Avila et al., 2017). These cells rapidly react to infection
and clear pathogens. To date, little information is available
on the interaction between neutrophil and SS2. It is critical
to study the response of neutrophils to SS2. In this study,
we examined the interaction between SS2 and neutrophils
and SS2 biofilm formation was increased in the presence of
neutrophils. SS2 biofilms can mediate neutrophil phagocytosis
evasion; however, SS2 biofilms can be killed by NETs, and
the bactericidal efficiency is comparable to the action of NETs
on planktonic SS2. Importantly, SS2 biofilm cells can inhibit
NET formation, mainly because of the biofilm extracellular
matrix.
Bacterial biofilms can exist in a range of host tissues in
the process of bacterial infection, which enables the bacterial
communities to persist in the host (Boles and Horswill, 2011).
From the perspective of the bacteria and host immune system
relationship, pathogens form biofilms to increase chances
of survival and to cause persistent infection in the host
(Watters et al., 2016). For example, biofilm formation provides
pneumococci with a protected environment for bacterial cells
and enables transmission from person to person during
nasopharyngeal colonization (Marks et al., 2013). Human
neutrophils can enhance the development of Pseudomonas
aeruginosa biofilms (Walker et al., 2005). In addition, previous
studies have reported that macrophages and monocytes increase
C. albicans biofilm formation (Chandra et al., 2007; Watters
et al., 2016). In this study, the results showed that neutrophils
can promote SS2 biofilm formation and that biofilm SS2 was
better able to survive than planktonic cells in macrophages and
neutrophils in vitro and in blood in vivo. To survive in the host,
resistance to phagocytes in the blood is a crucial event for the
pathogenicity of SS2 (Zhu et al., 2016). These findings suggest
that biofilm formation is a survival strategy utilized by SS2 to
evade phagocytosis. In addition, our results demonstrate that SS2
can form biofilms in some tissues such as the liver, spleen and
kidney in vivo.
In addition to phagocytosis, neutrophils release NETs to trap
and kill pathogens through extracellular DNA and antimicrobial
proteins (Thammavongsa et al., 2013). Various pathogens can be
killed by NETs including parasites, fungi, bacteria, and viruses
(Saitoh et al., 2012; Uchiyama et al., 2015; Avila et al., 2016; Von
Kockritz-Blickwede et al., 2016). It has previously been reported
that a microbe size-sensing mechanism allows neutrophils to
selectively respond to pathogens on the basis of microbe size.
Small microbes aremore likely to be taken up in a phagolysosome
instead of stimulating NET formation (Branzk et al., 2014).
One study showed that C. albicans with hyphae, which are
too large to be phagocytized, are large enough to induce NET
formation; however, C. albicans in yeast form failed to induce
NETs release and C. albicans biofilms impaired NET formation
(Branzk et al., 2014; Johnson et al., 2016). C. albicans biofilms
consist of two main kinds of cells, small oval yeast-form cells and
long tubular hyphal cells, and both yeast cells and hyphae are
crucial for biofilm formation. SS2 and many pathogenic bacteria
can induce NET formation. Therefore, virulence mechanisms
may have a critical role in NET formation and microbe
size may not the most important virulence mechanism that
induce NETs in response to bacterial stimuli. SS2 biofilms are
communities of bacteria with extracellular DNA, proteins and
exopolysaccharides. Importantly, biofilm extracellular matrix can
vary greatly depending on the microorganisms present. The
different properties between bacterial pathogens and the fungal
pathogen C. albicans may contribute to the different activities of
biofilms in response to neutrophils. Importantly, phagocytosis is
a much faster mechanism than NET formation and phagocytosis
remains the major method for host immune cells to clear invasive
SS2 cells (Fuchs et al., 2007; Nordenfelt and Tapper, 2011). A
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FIGURE 6 | NETs visualization and quantification. (A) Neutrophils were stimulated with planktonic SS2. The pictures from the left to right were labeled with the
following dyes: DNA with DAPI (blue), histone H4 (citrulline 3) with Alexa 568 conjugated (red), and an overlay of the first two pictures using ZEN 2012 software (Zeiss).
Scale bar, 10µm. (B) At 100 × magnification with oil, DNA was stained with the SYTO 9 green fluorescent nucleic stain. Arrows indicate the NETs structure; the round
shapes indicate free bacteria without entrapment, and the square shapes indicate bacteria entrapped by NET DNA. (C) Relative fluorescence units were used to
evaluate the quantity of NETs. Planktonic SS2 and bacteria separated from biofilm matrix could induce NETs release. The NET formation level induced by planktonic
SS2 with PMA was twice that induced by planktonic SS2. The NET formation induced by bacteria separated from biofilm matrix with PMA-treated neutrophils was
twice that induced by bacteria only. NETs induced by biofilm SS2 and the biofilm matrix were similar to the negative control. The results are depicted as the
mean ± SD (n = 5). **p < 0.01; ***p < 0.001; ns, no difference between groups.
reasonable hypothesis is that NETs aid in the killing of SS2 biofilm
cells that are difficult to phagocytose by immune cells and that
NETs appear to be an important method of eliminating SS2
biofilm cells.
Both planktonic SS2 and biofilm SS2 cells can cause neutrophil
accumulation at infection sites, providing an ideal environment
for NETs immunoreaction. Significantly, NETs appear to have
equal bactericidal efficacy for biofilm and planktonic SS2 cells.
Neutrophils were treated with DNase I and cytochalasin B to
degrade NETs and to suppress phagocytosis, respectively. For
planktonic SS2, when NETs and phagocytosis were suppressed
separately, the bacterial survival in neutrophils was improved
significantly. These results indicated that NET formation and
phagocytosis are both important mechanisms for killing invasive
planktonic SS2, which is consistent with previous reports (De
Buhr et al., 2017). Planktonic bacteria were more likely to be
cleared by phagocytosis. When NET DNA was degraded, the
survival of SS2 biofilm cells increased; however, phagocytosis had
no obvious bactericidal effect on biofilm bacteria. In addition,
in blood survival assays in vivo, biofilm cells were better able
to survive compared to planktonic cells. When NET DNA was
degraded, biofilms protected the bacteria from being killed and
biofilm cells had enhanced survival in vivo, indicating that NETs
could be an important bactericidal mechanism to entrap and kill
bacteria biofilms in the host blood stream. Both phagocytosis
and NETs are important bactericidal mechanisms for planktonic
cells, and planktonic SS2 can stimulate NETs release and can
be entrapped by NETs. NET formation appeared to be an
efficient bactericidal mechanism for biofilm cells in this study;
however, bacterial biofilms and the biofilm extracellular matrix
could inhibit NET formation even in the presence of PMA,
indicating that biofilms inhibit NETs release mainly through the
extracellular matrix. Notably, bacteria separated from biofilms
matrix still have the ability to induce NET formation. Further
work will address on the mechanism of NET inhibition through
biofilm matrix.
Secretion of nuclease has been themain strategy to degrade the
NET DNA backbone for bacteria in previous studies (Uchiyama
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FIGURE 7 | Bacteria survival rate in mouse blood. A comparison of the
survival rate of bacteria isolated from mouse blood post-infection between
planktonic and biofilm SS2 cells is shown. At 2, 4, 8, and 24 h post-infection,
there were significantly more viable biofilm SS2 cells than planktonic SS2 cells.
When DNase I was added to degrade NET DNA, the bacteria both in
planktonic state and biofilm state displayed enhanced survival in the blood,
particularly for biofilm SS2 cells. The survival rate between the group of
planktonic ZY with DNase I and the group of biofilm ZY with DNase I was
compared in each time point. The results are depicted as the mean ± SD
(n = 3). **p < 0.01; ***p < 0.001; ns, no difference between groups.
et al., 2012). In this study we found that biofilm is another
mechanism to inhibit NETs release. Importantly, SS2 biofilms
inhibit NETs release through the biofilm extracellular matrix.
Biofilms are significant protective shelters for bacteria and enable
survival by allowing the pathogen to persist and resist the
host immune system. Although biofilms can evade phagocytosis
and inhibit NET formation, NETs derived from neutrophils
stimulated by planktonic bacteria and host inflammatory factors
might be a significant mechanism of eliminating bacterial
biofilms. This study provides novel knowledge on the battles
between NETs and bacterial biofilms and can potentially inform
novel strategies for the clinical treatment of streptococcal disease.
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